{"id":61335,"date":"2026-10-29T10:23:06","date_gmt":"2026-10-29T07:23:06","guid":{"rendered":"https:\/\/thesauditimes.net\/en\/?p=61335"},"modified":"2026-10-29T10:23:06","modified_gmt":"2026-10-29T07:23:06","slug":"astrazeneca","status":"publish","type":"post","link":"https:\/\/thesauditimes.net\/en\/astrazeneca\/","title":{"rendered":"AstraZeneca: the British-Swedish drugmaker behind cancer and rare disease medicines"},"content":{"rendered":"<p>AstraZeneca PLC is a global biopharmaceutical company formed in 1999 through the merger of Astra AB of Sweden and Zeneca Group PLC of the UK. Its medicines are sold in more than 125 countries, and its shares trade in London, Stockholm and New York.<\/p>\n<p>The group is in focus because of its growth plan. It reported total revenue of $58.7 billion for 2025 and has set an ambition of $80 billion by 2030, with about 20 new medicines expected to launch before then.<\/p>\n<figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1920\" height=\"1440\" data-attachment-id=\"61414\" data-permalink=\"https:\/\/thesauditimes.net\/en\/astrazeneca\/astrazeneca-the-british-swedish-drugmaker-behind-cancer-and-rare-disease-medicines-2\/\" data-orig-file=\"https:\/\/thesauditimes.net\/en\/wp-content\/uploads\/2026\/10\/astrazeneca-photo-full.jpg\" data-orig-size=\"1920,1440\" data-comments-opened=\"0\" data-image-title=\"AstraZeneca: the British-Swedish drugmaker behind cancer and rare disease medicines\" data-image-description=\"\" data-image-caption=\"&lt;p&gt;AstraZeneca offices on the Cambridge Biomedical Campus in Cambridge, UK, 2026. Photo: Mr Ignavy, CC BY-SA 2.0, via Wikimedia Commons&lt;\/p&gt;\n\" data-large-file=\"https:\/\/thesauditimes.net\/en\/wp-content\/uploads\/2026\/10\/astrazeneca-photo-full-1024x768.jpg\" src=\"https:\/\/thesauditimes.net\/en\/wp-content\/uploads\/2026\/10\/astrazeneca-photo-full.jpg\" alt=\"AstraZeneca: the British-Swedish drugmaker behind cancer and rare disease medicines\" class=\"wp-image-61414\" srcset=\"https:\/\/thesauditimes.net\/en\/wp-content\/uploads\/2026\/10\/astrazeneca-photo-full.jpg 1920w, https:\/\/thesauditimes.net\/en\/wp-content\/uploads\/2026\/10\/astrazeneca-photo-full-300x225.jpg 300w, https:\/\/thesauditimes.net\/en\/wp-content\/uploads\/2026\/10\/astrazeneca-photo-full-1024x768.jpg 1024w, https:\/\/thesauditimes.net\/en\/wp-content\/uploads\/2026\/10\/astrazeneca-photo-full-768x576.jpg 768w, https:\/\/thesauditimes.net\/en\/wp-content\/uploads\/2026\/10\/astrazeneca-photo-full-1536x1152.jpg 1536w, https:\/\/thesauditimes.net\/en\/wp-content\/uploads\/2026\/10\/astrazeneca-photo-full-60x45.jpg 60w, https:\/\/thesauditimes.net\/en\/wp-content\/uploads\/2026\/10\/astrazeneca-photo-full-600x450.jpg 600w\" sizes=\"(max-width: 1920px) 100vw, 1920px\" \/><figcaption>AstraZeneca offices on the Cambridge Biomedical Campus in Cambridge, UK, 2026. Photo: Mr Ignavy, CC BY-SA 2.0, via Wikimedia Commons<\/figcaption><\/figure>\n<h3>Overview and Founding<\/h3>\n<p>The Swedish side of the company dates back to 1913, when a group of doctors and apothecaries founded Astra AB in S\u00f6dert\u00e4lje. Astra later set up research sites in Gothenburg in 1954 and in Lund in 1955.<\/p>\n<p>The British side grew out of Imperial Chemical Industries, which created ICI Pharmaceuticals in 1957. In 1993 ICI demerged its pharmaceuticals business, which became Zeneca Group PLC.<\/p>\n<p>Both companies had already built a presence abroad before they joined. ICI opened a factory in Macclesfield in 1966 and expanded into the United States in 1972, while Astra agreed in 1982 to work with MSD in the American market. Zeneca set up its first presence in China in 1993.<\/p>\n<p>Astra and Zeneca merged in 1999 to form AstraZeneca. The company keeps its headquarters in the UK and runs major research centres in Cambridge, Gaithersburg, Boston, Gothenburg, Shanghai and Beijing.<\/p>\n<h3>Key Milestones<\/h3>\n<ul>\n<li><b>1913:<\/b> Astra AB is founded in S\u00f6dert\u00e4lje, Sweden.<\/li>\n<li><b>1993:<\/b> ICI demerges its pharmaceuticals business to form Zeneca Group PLC.<\/li>\n<li><b>1999:<\/b> Astra AB and Zeneca PLC merge to create AstraZeneca.<\/li>\n<li><b>2007:<\/b> AstraZeneca acquires MedImmune, a year after buying Cambridge Antibody Technology.<\/li>\n<li><b>2012:<\/b> Pascal Soriot becomes chief executive on 1 October.<\/li>\n<li><b>2014:<\/b> The board rejects a final Pfizer proposal valued at about $119 billion.<\/li>\n<li><b>2020:<\/b> AstraZeneca and the University of Oxford agree to develop and distribute a COVID-19 vaccine.<\/li>\n<li><b>2021:<\/b> The company completes the purchase of Alexion and opens the Discovery Centre in Cambridge.<\/li>\n<li><b>2026:<\/b> Ordinary shares begin trading on the New York Stock Exchange on 2 February.<\/li>\n<\/ul>\n<h3>What It Does<\/h3>\n<p>AstraZeneca discovers, develops, makes and sells prescription medicines. Its main areas are oncology, cardiovascular, renal and metabolism, respiratory and immunology, infectious disease and rare disease.<\/p>\n<p>Rare disease work is run through Alexion, which AstraZeneca bought in July 2021 for about $13.3 billion in cash plus new shares. The company called the deal its entry into medicines for rare diseases, a field that regulators such as the Saudi Food and Drug Authority are also trying to speed up through <a href=\"https:\/\/thesauditimes.net\/en\/saudi-fda-launches-nader-program-to-accelerate-development-and-access-to-rare-disease-medicines\/\">dedicated approval programs<\/a>.<\/p>\n<p>During the COVID-19 pandemic the company made the vaccine developed with Oxford. About 3 billion doses had been delivered to more than 180 countries by June 2022, first at no profit and later mostly at cost.<\/p>\n<p>Its 2025 results showed core earnings per share of $9.16, and the company counted 43 regulatory approvals in major regions over the previous twelve months. Since February 2026 its ordinary shares have also traded on the New York Stock Exchange under the ticker AZN, replacing an earlier Nasdaq listing of depositary shares.<\/p>\n<p>In 2023 it launched Evinova, a health technology business. In 2025 it announced a $2.5 billion research centre in Beijing and plans to invest $50 billion in medicines manufacturing and research in the United States by 2030.<\/p>\n<p>Its staff also take part in regional health events. A director for commercial IT and digital at AstraZeneca spoke at a health technology session covered in our report on <a href=\"https:\/\/thesauditimes.net\/en\/three-industries-one-kingdom-why-ai-gaming-and-blockchain-all-came-to-riyadh\/\">why AI, gaming and blockchain came to Riyadh<\/a>.<\/p>\n<h3>In Numbers<\/h3>\n<ul>\n<li>Total revenue: $58.7 billion (2025)<\/li>\n<li>Product sales: $55.6 billion (2025)<\/li>\n<li>Investment in science: $14.2 billion (2025)<\/li>\n<li>Employees: 96,100 (Annual Report 2025)<\/li>\n<li>Revenue ambition: $80 billion by 2030 (set in May 2024)<\/li>\n<li>Countries where its medicines are sold: more than 125 (2026)<\/li>\n<\/ul>\n<h3>Leadership<\/h3>\n<p>The company is led by Chief Executive Officer and Executive Director <a href=\"https:\/\/thesauditimes.net\/en\/pascal-soriot\/\">Pascal Soriot<\/a>, who has held the post since October 2012.<\/p>\n<p>Michel Demar\u00e9 is Non-Executive Chair of the Board, and Aradhana Sarin is Executive Director and Chief Financial Officer.<\/p>\n<p>Marc Dunoyer serves as Chief Executive Officer of Alexion and Chief Strategy Officer of AstraZeneca. The oncology business is headed by David Fredrickson, Executive Vice-President, Oncology Business Unit.<\/p>\n<div class=\"refs\">\n<h3>References<\/h3>\n<p><b>Internal<\/b><\/p>\n<ul>\n<li><a href=\"https:\/\/thesauditimes.net\/en\/pascal-soriot\/\">Pascal Soriot, AstraZeneca Chief Executive Leading Its $80 Billion Growth Plan<\/a><\/li>\n<li><a href=\"https:\/\/thesauditimes.net\/en\/saudi-fda-launches-nader-program-to-accelerate-development-and-access-to-rare-disease-medicines\/\">Saudi FDA launches &#8220;Nader&#8221; program to accelerate development and access to rare disease medicines<\/a><\/li>\n<li><a href=\"https:\/\/thesauditimes.net\/en\/three-industries-one-kingdom-why-ai-gaming-and-blockchain-all-came-to-riyadh\/\">Three Industries, One Kingdom: Why AI, Gaming and Blockchain All Came to Riyadh<\/a><\/li>\n<\/ul>\n<p><b>External<\/b><\/p>\n<ul>\n<li><a href=\"https:\/\/www.astrazeneca.com\/our-company.html\" target=\"_blank\" rel=\"noopener\">AstraZeneca: Our company<\/a> \u2014 2026<\/li>\n<li><a href=\"https:\/\/www.astrazeneca.com\/our-company\/history.html\" target=\"_blank\" rel=\"noopener\">AstraZeneca: Our history<\/a> \u2014 2026<\/li>\n<li><a href=\"https:\/\/www.astrazeneca.com\/our-company\/leadership.html\" target=\"_blank\" rel=\"noopener\">AstraZeneca: Leadership<\/a> \u2014 2026<\/li>\n<li><a href=\"https:\/\/www.biospace.com\/press-releases\/astrazeneca-results-fy-and-q4-2025\" target=\"_blank\" rel=\"noopener\">BioSpace: AstraZeneca results FY and Q4 2025<\/a> \u2014 2026<\/li>\n<li><a href=\"https:\/\/www.astrazeneca.com\/media-centre\/press-releases\/2026\/astrazeneca-to-complete-direct-listing-on-NYSE.html\" target=\"_blank\" rel=\"noopener\">AstraZeneca: Direct listing of ordinary shares on the New York Stock Exchange<\/a> \u2014 2026<\/li>\n<li><a href=\"https:\/\/www.astrazeneca.com\/media-centre\/press-releases\/2021\/acquisition-of-alexion-completed.html\" target=\"_blank\" rel=\"noopener\">AstraZeneca: Acquisition of Alexion completed<\/a> \u2014 2021<\/li>\n<\/ul>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>AstraZeneca PLC is a British-Swedish biopharmaceutical group formed in 1999. It reported $58.7 billion in revenue for 2025 and aims for $80 billion by 2030.<\/p>\n","protected":false},"author":1,"featured_media":61336,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[13199],"tags":[],"class_list":["post-61335","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-entities"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AstraZeneca: History, Medicines and Key Figures<\/title>\n<meta name=\"description\" content=\"AstraZeneca PLC, formed in 1999 from Astra and Zeneca, sells medicines in over 125 countries. Its history, milestones, 2025 revenue and leadership explained.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/thesauditimes.net\/en\/astrazeneca\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AstraZeneca: History, Medicines and Key Figures\" \/>\n<meta property=\"og:description\" content=\"AstraZeneca PLC, formed in 1999 from Astra and Zeneca, sells medicines in over 125 countries. Its history, milestones, 2025 revenue and leadership explained.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thesauditimes.net\/en\/astrazeneca\/\" \/>\n<meta property=\"og:site_name\" content=\"The Saudi Times\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TheSaudiTime\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-29T07:23:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/thesauditimes.net\/en\/wp-content\/uploads\/2026\/10\/astrazeneca-logo.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"1000\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"The Saudi Times\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@thesauditimes_\" \/>\n<meta name=\"twitter:site\" content=\"@thesauditimes_\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"The Saudi Times\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/astrazeneca\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/astrazeneca\\\/\"},\"author\":{\"name\":\"The Saudi Times\",\"@id\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/#\\\/schema\\\/person\\\/ba8713cb31d87743608f3311cd180cd0\"},\"headline\":\"AstraZeneca: the British-Swedish drugmaker behind cancer and rare disease medicines\",\"datePublished\":\"2026-10-29T07:23:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/astrazeneca\\\/\"},\"wordCount\":741,\"publisher\":{\"@id\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/astrazeneca\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/astrazeneca-logo.png\",\"articleSection\":[\"Entities\"],\"inLanguage\":\"en-US\",\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/astrazeneca\\\/\",\"url\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/astrazeneca\\\/\",\"name\":\"AstraZeneca: History, Medicines and Key Figures\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/astrazeneca\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/astrazeneca\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/astrazeneca-logo.png\",\"datePublished\":\"2026-10-29T07:23:06+00:00\",\"description\":\"AstraZeneca PLC, formed in 1999 from Astra and Zeneca, sells medicines in over 125 countries. Its history, milestones, 2025 revenue and leadership explained.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/astrazeneca\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/thesauditimes.net\\\/en\\\/astrazeneca\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/astrazeneca\\\/#primaryimage\",\"url\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/astrazeneca-logo.png\",\"contentUrl\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/astrazeneca-logo.png\",\"width\":800,\"height\":1000,\"caption\":\"Logo of AstraZeneca\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/astrazeneca\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Entities\",\"item\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/category\\\/entities\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"AstraZeneca: the British-Swedish drugmaker behind cancer and rare disease medicines\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/\",\"name\":\"The Saudi Times\",\"description\":\"Saudi Arabia News, Business and Culture\",\"publisher\":{\"@id\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/#organization\"},\"alternateName\":[\"\u0633\u0639\u0648\u062f\u064a \u062a\u0627\u064a\u0645\u0632\",\"\u0627\u0644\u062a\u0627\u064a\u0645\u0632 \u0627\u0644\u0633\u0639\u0648\u062f\u064a\u0629\"],\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\",\"sameAs\":[\"https:\\\/\\\/thesauditimes.net\\\/\"]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/#organization\",\"name\":\"The Saudi Times\",\"alternateName\":[\"\u0633\u0639\u0648\u062f\u064a \u062a\u0627\u064a\u0645\u0632\",\"\u0627\u0644\u062a\u0627\u064a\u0645\u0632 \u0627\u0644\u0633\u0639\u0648\u062f\u064a\u0629\"],\"url\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/The-Saudi-Times.jpeg\",\"contentUrl\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/The-Saudi-Times.jpeg\",\"width\":1280,\"height\":1280,\"caption\":\"The Saudi Times\"},\"image\":{\"@id\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/TheSaudiTime\",\"https:\\\/\\\/x.com\\\/thesauditimes_\",\"https:\\\/\\\/www.instagram.com\\\/thesauditime\\\/\",\"https:\\\/\\\/thesauditimes.net\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/#\\\/schema\\\/person\\\/ba8713cb31d87743608f3311cd180cd0\",\"name\":\"The Saudi Times\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/s-bb-Copy-96x96.png\",\"url\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/s-bb-Copy-96x96.png\",\"contentUrl\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/s-bb-Copy-96x96.png\",\"caption\":\"The Saudi Times\"},\"sameAs\":[\"https:\\\/\\\/thesauditimes.net\\\/en\"],\"url\":\"https:\\\/\\\/thesauditimes.net\\\/en\\\/author\\\/ttaaamm84\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AstraZeneca: History, Medicines and Key Figures","description":"AstraZeneca PLC, formed in 1999 from Astra and Zeneca, sells medicines in over 125 countries. Its history, milestones, 2025 revenue and leadership explained.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/thesauditimes.net\/en\/astrazeneca\/","og_locale":"en_US","og_type":"article","og_title":"AstraZeneca: History, Medicines and Key Figures","og_description":"AstraZeneca PLC, formed in 1999 from Astra and Zeneca, sells medicines in over 125 countries. Its history, milestones, 2025 revenue and leadership explained.","og_url":"https:\/\/thesauditimes.net\/en\/astrazeneca\/","og_site_name":"The Saudi Times","article_publisher":"https:\/\/www.facebook.com\/TheSaudiTime","article_published_time":"2026-10-29T07:23:06+00:00","og_image":[{"width":800,"height":1000,"url":"https:\/\/thesauditimes.net\/en\/wp-content\/uploads\/2026\/10\/astrazeneca-logo.png","type":"image\/png"}],"author":"The Saudi Times","twitter_card":"summary_large_image","twitter_creator":"@thesauditimes_","twitter_site":"@thesauditimes_","twitter_misc":{"Written by":"The Saudi Times","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/thesauditimes.net\/en\/astrazeneca\/#article","isPartOf":{"@id":"https:\/\/thesauditimes.net\/en\/astrazeneca\/"},"author":{"name":"The Saudi Times","@id":"https:\/\/thesauditimes.net\/en\/#\/schema\/person\/ba8713cb31d87743608f3311cd180cd0"},"headline":"AstraZeneca: the British-Swedish drugmaker behind cancer and rare disease medicines","datePublished":"2026-10-29T07:23:06+00:00","mainEntityOfPage":{"@id":"https:\/\/thesauditimes.net\/en\/astrazeneca\/"},"wordCount":741,"publisher":{"@id":"https:\/\/thesauditimes.net\/en\/#organization"},"image":{"@id":"https:\/\/thesauditimes.net\/en\/astrazeneca\/#primaryimage"},"thumbnailUrl":"https:\/\/thesauditimes.net\/en\/wp-content\/uploads\/2026\/10\/astrazeneca-logo.png","articleSection":["Entities"],"inLanguage":"en-US","copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/thesauditimes.net\/en\/#organization"}},{"@type":"WebPage","@id":"https:\/\/thesauditimes.net\/en\/astrazeneca\/","url":"https:\/\/thesauditimes.net\/en\/astrazeneca\/","name":"AstraZeneca: History, Medicines and Key Figures","isPartOf":{"@id":"https:\/\/thesauditimes.net\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/thesauditimes.net\/en\/astrazeneca\/#primaryimage"},"image":{"@id":"https:\/\/thesauditimes.net\/en\/astrazeneca\/#primaryimage"},"thumbnailUrl":"https:\/\/thesauditimes.net\/en\/wp-content\/uploads\/2026\/10\/astrazeneca-logo.png","datePublished":"2026-10-29T07:23:06+00:00","description":"AstraZeneca PLC, formed in 1999 from Astra and Zeneca, sells medicines in over 125 countries. Its history, milestones, 2025 revenue and leadership explained.","breadcrumb":{"@id":"https:\/\/thesauditimes.net\/en\/astrazeneca\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thesauditimes.net\/en\/astrazeneca\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thesauditimes.net\/en\/astrazeneca\/#primaryimage","url":"https:\/\/thesauditimes.net\/en\/wp-content\/uploads\/2026\/10\/astrazeneca-logo.png","contentUrl":"https:\/\/thesauditimes.net\/en\/wp-content\/uploads\/2026\/10\/astrazeneca-logo.png","width":800,"height":1000,"caption":"Logo of AstraZeneca"},{"@type":"BreadcrumbList","@id":"https:\/\/thesauditimes.net\/en\/astrazeneca\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/thesauditimes.net\/en\/"},{"@type":"ListItem","position":2,"name":"Entities","item":"https:\/\/thesauditimes.net\/en\/category\/entities\/"},{"@type":"ListItem","position":3,"name":"AstraZeneca: the British-Swedish drugmaker behind cancer and rare disease medicines"}]},{"@type":"WebSite","@id":"https:\/\/thesauditimes.net\/en\/#website","url":"https:\/\/thesauditimes.net\/en\/","name":"The Saudi Times","description":"Saudi Arabia News, Business and Culture","publisher":{"@id":"https:\/\/thesauditimes.net\/en\/#organization"},"alternateName":["\u0633\u0639\u0648\u062f\u064a \u062a\u0627\u064a\u0645\u0632","\u0627\u0644\u062a\u0627\u064a\u0645\u0632 \u0627\u0644\u0633\u0639\u0648\u062f\u064a\u0629"],"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thesauditimes.net\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US","sameAs":["https:\/\/thesauditimes.net\/"]},{"@type":"Organization","@id":"https:\/\/thesauditimes.net\/en\/#organization","name":"The Saudi Times","alternateName":["\u0633\u0639\u0648\u062f\u064a \u062a\u0627\u064a\u0645\u0632","\u0627\u0644\u062a\u0627\u064a\u0645\u0632 \u0627\u0644\u0633\u0639\u0648\u062f\u064a\u0629"],"url":"https:\/\/thesauditimes.net\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thesauditimes.net\/en\/#\/schema\/logo\/image\/","url":"https:\/\/thesauditimes.net\/en\/wp-content\/uploads\/2024\/05\/The-Saudi-Times.jpeg","contentUrl":"https:\/\/thesauditimes.net\/en\/wp-content\/uploads\/2024\/05\/The-Saudi-Times.jpeg","width":1280,"height":1280,"caption":"The Saudi Times"},"image":{"@id":"https:\/\/thesauditimes.net\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/TheSaudiTime","https:\/\/x.com\/thesauditimes_","https:\/\/www.instagram.com\/thesauditime\/","https:\/\/thesauditimes.net\/"]},{"@type":"Person","@id":"https:\/\/thesauditimes.net\/en\/#\/schema\/person\/ba8713cb31d87743608f3311cd180cd0","name":"The Saudi Times","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thesauditimes.net\/en\/wp-content\/uploads\/2025\/09\/s-bb-Copy-96x96.png","url":"https:\/\/thesauditimes.net\/en\/wp-content\/uploads\/2025\/09\/s-bb-Copy-96x96.png","contentUrl":"https:\/\/thesauditimes.net\/en\/wp-content\/uploads\/2025\/09\/s-bb-Copy-96x96.png","caption":"The Saudi Times"},"sameAs":["https:\/\/thesauditimes.net\/en"],"url":"https:\/\/thesauditimes.net\/en\/author\/ttaaamm84\/"}]}},"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/pgnDiS-fXh","jetpack_featured_media_url":"https:\/\/thesauditimes.net\/en\/wp-content\/uploads\/2026\/10\/astrazeneca-logo.png","_links":{"self":[{"href":"https:\/\/thesauditimes.net\/en\/wp-json\/wp\/v2\/posts\/61335","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thesauditimes.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thesauditimes.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thesauditimes.net\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thesauditimes.net\/en\/wp-json\/wp\/v2\/comments?post=61335"}],"version-history":[{"count":2,"href":"https:\/\/thesauditimes.net\/en\/wp-json\/wp\/v2\/posts\/61335\/revisions"}],"predecessor-version":[{"id":61415,"href":"https:\/\/thesauditimes.net\/en\/wp-json\/wp\/v2\/posts\/61335\/revisions\/61415"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/thesauditimes.net\/en\/wp-json\/wp\/v2\/media\/61336"}],"wp:attachment":[{"href":"https:\/\/thesauditimes.net\/en\/wp-json\/wp\/v2\/media?parent=61335"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thesauditimes.net\/en\/wp-json\/wp\/v2\/categories?post=61335"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thesauditimes.net\/en\/wp-json\/wp\/v2\/tags?post=61335"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}